CapsoVision (CV) EBT (2024 - 2025)
CapsoVision (CV) reported EBT of -$7.4 million for Q4 2025, down 59.25% on a YoY basis from -$18.1 million in Q4 2024, and up 6.96% sequentially from -$7.9 million in Q3 2025.
CapsoVision (CV) EBT (2024 - 2025) Analysis & Trends
CapsoVision (CV) has 2 years of EBT data on file, last reported at -$7.4 million in Q4 2025.
- For the quarter ending Q4 2025, EBT fell 59.25% year-over-year to -$7.4 million; the trailing twelve-month figure through Dec 2025 stood at -$24.5 million (changed N/A YoY), and the FY2025 full-year result was -$25.3 million, down 27.17% from the prior year.
- EBT grew to -$7.4 million in Q4 2025, from -$7.9 million in the prior quarter.
- In the past five years, EBT ranged from a high of -$4.6 million in Q2 2025 to a low of -$7.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.45 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 850.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.83 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.16 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 459.00 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 269.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 222.44 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 505.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | CapsoVision | 162.07 Mn | 151.95 Mn | 1.95 Mn | -7.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -7.37 Mn |
| Sep 30, 2025 | -7.92 Mn |
| Jun 30, 2025 | -4.63 Mn |
| Dec 31, 2024 | -4.63 Mn |
| Sep 30, 2024 | -5.79 Mn |
| Jun 30, 2024 | -5.27 Mn |